Galmed Pharmaceuticals (GLMD) has released an update.
Galmed Pharmaceuticals Ltd. announced the adjournment of its Annual General Meeting (AGM) initially scheduled for July 10, 2024, due to a lack of quorum. The AGM has been rescheduled to take place a week later on July 17, 2024, at the company’s legal counsel’s office in Ramat Gan, Israel. This announcement is relevant for stakeholders who track the company’s governance and legal filings.
For further insights into GLMD stock, check out TipRanks’ Stock Analysis page.
